SAKK & Celgene’s «HEM Pioneer» Grant
In 2019 SAKK & Celgene’s «HEM Pioneer» Grant will be awarded for the first time to support pioneering ideas to fight blood cancer.
Many types of blood cancer remain incurable and are associated with severe morbidity and increased mortality. SAKK’s HEM Pioneer Grant is funded by Celgene and aims to support projects and research that could potentially pave the way for a game changing outcome in the field of blood cancers.
Key information about the Grant
- Grant is endowed with CHF 50’000.–
- Application deadline is April 30, 2019
- Your application must be submitted electronically via this webpage
Further details of the award and the rules can be found on www.hempioneer.ch